These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 31216262)

  • 61. [Autophagy is involved in doxorubicin induced resistance of human myeloma cell line RPMI8226].
    Pan YZ; Wang X; Bai H; Wang CB; Zhang Q; Xi R
    Zhonghua Xue Ye Xue Za Zhi; 2013 Jun; 34(6):489-92. PubMed ID: 23827103
    [TBL] [Abstract][Full Text] [Related]  

  • 62. DOX-Vit D, a Novel Doxorubicin Delivery Approach, Inhibits Human Osteosarcoma Cell Proliferation by Inducing Apoptosis While Inhibiting Akt and mTOR Signaling Pathways.
    Maayah ZH; Zhang T; Forrest ML; Alrushaid S; Doschak MR; Davies NM; El-Kadi AOS
    Pharmaceutics; 2018 Sep; 10(3):. PubMed ID: 30181466
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effects of ZEB1 on regulating osteosarcoma cells via NF-κB/iNOS.
    Xu XM; Liu W; Cao ZH; Liu MX
    Eur Rev Med Pharmacol Sci; 2017 Mar; 21(6):1184-1190. PubMed ID: 28387915
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Intrinsic resistance to chemotherapeutic agents in murine osteosarcoma cells.
    Takeshita H; Kusuzaki K; Ashihara T; Gebhardt MC; Mankin HJ; Hirasawa Y
    J Bone Joint Surg Am; 2000 Jul; 82-A(7):963-9. PubMed ID: 10901311
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Overexpression of ZEB1 relates to metastasis and invasion in osteosarcoma.
    Shen A; Zhang Y; Yang H; Xu R; Huang G
    J Surg Oncol; 2012 Jun; 105(8):830-4. PubMed ID: 22213004
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Selective targeting of FAK-Pyk2 axis by alpha-naphthoflavone abrogates doxorubicin resistance in breast cancer cells.
    Datta A; Bhasin N; Kim H; Ranjan M; Rider B; Abd Elmageed ZY; Mondal D; Agrawal KC; Abdel-Mageed AB
    Cancer Lett; 2015 Jun; 362(1):25-35. PubMed ID: 25796439
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Doxorubicin-Hyaluronan Conjugated Super-Paramagnetic Iron Oxide Nanoparticles (DOX-HA-SPION) Enhanced Cytoplasmic Uptake of Doxorubicin and Modulated Apoptosis, IL-6 Release and NF-kappaB Activity in Human MDA-MB-231 Breast Cancer Cells.
    Vyas D; Lopez-Hisijos N; Gandhi S; El-Dakdouki M; Basson MD; Walsh MF; Huang X; Vyas AK; Chaturvedi LS
    J Nanosci Nanotechnol; 2015 Sep; 15(9):6413-22. PubMed ID: 26690867
    [TBL] [Abstract][Full Text] [Related]  

  • 68. IL-6 is involved in malignancy and doxorubicin sensitivity of renal carcinoma cells.
    Chen Y; Liu J; Lv P; Gao J; Wang M; Wang Y
    Cell Adh Migr; 2018 Jan; 12(1):28-36. PubMed ID: 28328292
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Endoplasmic reticulum-targeting doxorubicin: a new tool effective against doxorubicin-resistant osteosarcoma.
    Buondonno I; Gazzano E; Tavanti E; Chegaev K; Kopecka J; Fanelli M; Rolando B; Fruttero R; Gasco A; Hattinger C; Serra M; Riganti C
    Cell Mol Life Sci; 2019 Feb; 76(3):609-625. PubMed ID: 30430199
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Proteinase-3, a serine protease which mediates doxorubicin-induced apoptosis in the HL-60 leukemia cell line, is downregulated in its doxorubicin-resistant variant.
    Wu CH; Gordon J; Rastegar M; Ogretmen B; Safa AR
    Oncogene; 2002 Aug; 21(33):5160-74. PubMed ID: 12140766
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Nanoparticle-directed sub-cellular localization of doxorubicin and the sensitization breast cancer cells by circumventing GST-mediated drug resistance.
    Zeng X; Morgenstern R; Nyström AM
    Biomaterials; 2014 Jan; 35(4):1227-39. PubMed ID: 24210875
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Interleukin-9 aggravates doxorubicin-induced cardiotoxicity by promoting inflammation and apoptosis in mice.
    Ye D; Wang Z; Xu Y; Ye J; Wang M; Liu J; Zhang J; Zhao M; Chen J; Wan J
    Life Sci; 2020 Aug; 255():117844. PubMed ID: 32464124
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Evaluation of systemic chemotherapy with magnetic liposomal doxorubicin and a dipole external electromagnet.
    Nobuto H; Sugita T; Kubo T; Shimose S; Yasunaga Y; Murakami T; Ochi M
    Int J Cancer; 2004 Apr; 109(4):627-35. PubMed ID: 14991586
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Reactive oxygen species mediate doxorubicin induced p53-independent apoptosis.
    Tsang WP; Chau SP; Kong SK; Fung KP; Kwok TT
    Life Sci; 2003 Sep; 73(16):2047-58. PubMed ID: 12899928
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Selective sensitization of retinoblastoma protein-deficient sarcoma cells to doxorubicin by flavopiridol-mediated inhibition of cyclin-dependent kinase 2 kinase activity.
    Li W; Fan J; Bertino JR
    Cancer Res; 2001 Mar; 61(6):2579-82. PubMed ID: 11289134
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Interplay Between Long Noncoding RNA ZEB1-AS1 and miR-200s Regulates Osteosarcoma Cell Proliferation and Migration.
    Liu C; Pan C; Cai Y; Wang H
    J Cell Biochem; 2017 Aug; 118(8):2250-2260. PubMed ID: 28075045
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effects of monensin liposomes on the cytotoxicity, apoptosis and expression of multidrug resistance genes in doxorubicin-resistant human breast tumour (MCF-7/dox) cell-line.
    Shaik MS; Chatterjee A; Singh M
    J Pharm Pharmacol; 2004 Jul; 56(7):899-907. PubMed ID: 15233869
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Multidrug (pleiotropic) resistance in doxorubicin-selected variants of the human sarcoma cell line MES-SA.
    Harker WG; Sikic BI
    Cancer Res; 1985 Sep; 45(9):4091-6. PubMed ID: 4028002
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pathophysiological roles of autophagy and aldo-keto reductases in development of doxorubicin resistance in gastrointestinal cancer cells.
    Matsunaga T; Kawabata S; Yanagihara Y; Kezuka C; Kato M; Morikawa Y; Endo S; Chen H; Iguchi K; Ikari A
    Chem Biol Interact; 2019 Dec; 314():108839. PubMed ID: 31563593
    [TBL] [Abstract][Full Text] [Related]  

  • 80. miR-27b-3p is Involved in Doxorubicin Resistance of Human Anaplastic Thyroid Cancer Cells via Targeting Peroxisome Proliferator-Activated Receptor Gamma.
    Xu Y; Han YF; Ye B; Zhang YL; Dong JD; Zhu SJ; Chen J
    Basic Clin Pharmacol Toxicol; 2018 Dec; 123(6):670-677. PubMed ID: 29924913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.